Literature DB >> 17357892

[Prevalence of diabetic retinopathy in the city of Badajoz 2002 (Extremadura project to prevent blindness)].

E Santos-Bueso1, C Fernández-Pérez, A Macarro, J Fernández-Vigo.   

Abstract

OBJECTIVE: To establish the prevalence of diabetic retinopathy (DR), types and risk factors in a diabetic population in the city of Badajoz.
METHODS: A cross-sectional study, with prospective data collection, was performed in 2002 on 762 randomly selected diabetic patients belonging to two Primary Care Centers. We evaluated age, gender, type, treatment, duration of diabetes and blood pressure levels. Two color fundus photographs were taken and ophthalmoscopy performed on both eyes. Data were analyzed using SPSS (11.5).
RESULTS: The mean age of the patients was 66.2 (DS 11.4) years, 4.7% were type 1 diabetics, 29% were insulin-treated and 52.8% had elevated blood pressure. Prevalence of DR was 29.8%, macular edema 1.4% and proliferative DR 4.8%. Multivariate analysis showed that patients with an evolution of between 5 and 10 years had a frequency 1.13 times higher (ORaj 1.13; IC 95% 0.68-1.88; p=0.648) than those of less than 5 years evolution, while those with more than 15 years evolution had a frequency 3.12 times higher (ORaj 3.12; IC 95% 1.85-5.26; p<0.001). Patients receiving treatment with oral antidiabetic agents had an RD prevalence 2.39 times higher (ORaj 2.39; IC 95% 1.21-4.74; p=0,012) than those treated with diet only. Patients treated with insulin had a 10.32 higher frequency (ORaj 10.32; IC 95% 5.07-21.00; p<0.001) than those treated with diet.
CONCLUSIONS: 29.8% of the diabetic population in the city of Badajoz is affected by DR. Although this prevalence is lower than that observed in previous studies performed by the same team, further studies should be carried out to detect risk sub-groups to allow us to act to decrease such a high prevalence.

Entities:  

Mesh:

Year:  2007        PMID: 17357892     DOI: 10.4321/s0365-66912007000300007

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  5 in total

1.  [Prevalence and risk factors associated with diabetic retinopathy in Santander. Northern Spain].

Authors:  José María Castillo-Otí; Joaquín Cañal-Villanueva; María Teresa García-Unzueta; Ana Isabel Galván-Manso; María Rosa Callejas-Herrero; Pedro Muñoz-Cacho
Journal:  Aten Primaria       Date:  2019-05-17       Impact factor: 1.137

2.  Vitamin D Deficiency Is Significantly Associated with Retinopathy in Type 2 Diabetes Mellitus: A Case-Control Study.

Authors:  José M Castillo-Otí; Ana I Galván-Manso; María R Callejas-Herrero; Luís A Vara-González; Fernando Salas-Herrera; Pedro Muñoz-Cacho
Journal:  Nutrients       Date:  2021-12-25       Impact factor: 5.717

Review 3.  Changes in the Epidemiology of Diabetic Retinopathy in Spain: A Systematic Review and Meta-Analysis.

Authors:  Pedro Romero-Aroca; Maribel López-Galvez; Maria Asuncion Martinez-Brocca; Alicia Pareja-Ríos; Sara Artola; Josep Franch-Nadal; Joan Fernandez-Ballart; José Andonegui; Marc Baget-Bernaldiz
Journal:  Healthcare (Basel)       Date:  2022-07-16

4.  Expert Panel Consensus for Addressing Anti-VEGF Treatment Challenges of Diabetic Macular Edema in Spain.

Authors:  José Ignacio Fernández-Vigo; Inés Contreras; María José Crespo; Carlos Beckford; Ignacio Flores-Moreno; Rosario Cobo-Soriano; Jesús Pareja; María Dolores Martín; Luis Moreno; Luis Arrevola-Velasco
Journal:  Clin Ophthalmol       Date:  2022-09-19

5.  Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study.

Authors:  Miguel Á Salinero-Fort; Francisco Javier San Andrés-Rebollo; Carmen de Burgos-Lunar; Francisco Jesús Arrieta-Blanco; Paloma Gómez-Campelo
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.